Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy
Bibliographic Data
| ID | 14740829 |
|---|---|
| Authors | Mianzhi Zhang (0000-0002-2446-9829), Miao Liu (0000-0002-1765-1411), Min Xiong (0000-0001-9627-6324, Nankai University), Junbo Gong (0000-0002-3376-3296, Tianjin Institute of Pharmaceutical Research (China)), Xiaoyue Tan (0000-0001-9989-0573, Nankai University, corresponding author) |
| Year | 2012 |
| Volume | 141 |
| Issue | 1 |
| Pages | 111-118 |
| Publication date | 2012-05-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2012.02.007 |
| PMID | 22353431 |
| OpenAlex | W1997753501 |
| Language | EN |
| Citations received | 4 |
| References cited | 33 |
Albuminuria · Diabetes mellitus · Diabetic nephropathy · Kidney · Nephropathy · Pathology · Podocyte · Proteinuria · Schisandra chinensis · Streptozotocin · Traditional Chinese medicine · Traditional medicine · Chronic Kidney Disease and Diabetes · Medicine · Plant-derived Lignans Synthesis and Bioactivity · Renal Diseases and Glomerulopathies · Endocrinology · Pharmacology
Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy
Pancreas protective effects of Urolithin A on type 2 diabetic mice induced by high fat and streptozotocin via regulating autophagy and AKT/mTOR signaling pathway
Unraveling the mechanisms of Schisandra Chinensis Mixture against diabetic nephropathy by integrating serum pharmacochemistry, network pharmacology, transcriptomics, and metabolomics
Improvement of Cisplatin-induced renal dysfunction by Schisandra chinensis stems via anti-inflammation and anti-apoptosis effects
| Unique citing works | 4 |
|---|---|
| Citations per year | 0,5 |
| Citation span | 2018 - 2026 (9) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 4 |